Searched for
ROBERT WESSMAN
Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatmentDr. Reddy's Laboratories has partnered with Alvotech to co-develop and commercialize a biosimilar for pembrolizumab (Keytruda), a crucial c...
Alvotech, Dr. Reddy's ink pact for commercialisation of denosumabAlvotech and Dr. Reddy's partner for AVT03, a biosimilar to Prolia and Xgeva, treating osteoporosis and skeletal-related events. The agreem...
- Actavis acquires Sanmar subsidiary
Actavis Group, the global generic pharma company, has announced the acquisition of the Active Pharmaceutical Ingredient (API).